// App-Quantinova.ai

TCT-556 : Differences in neointimal coverage among bare-metal stent, zotarolimus-eluting stent, everolimus-eluting stent and biolimus-eluting stent at 9 months after implantation using optical coherence tomography in patients with ST-segment elevation myocardial infarction

Researchers

Presenter

  • Koichiro Sonoda

Principal Investigators

  • Shiro Hata

  • Satoshi Ikeda

  • Seiji Koga

  • Koji Maemura

Medical Centers

  • Sasebo City General Hospital, Sasebo, Japan

  • Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

  • Mofezolac

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim